Профиль компании
- Фондовый код
- ABVX
- ISIN-код
- US00370M1036
- Валюта
- US Dollar (USD)
- Дата IPO
- 2023-10-20

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC...